Haleon Plc (HLNCF)
5.19
+0.38
(+7.90%)
USD |
OTCM |
Aug 24, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 45.54B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 7.72% |
| Valuation | |
| PE Ratio | 21.35 |
| PE Ratio (Forward) | |
| PS Ratio | 3.105 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0321 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom. |
| URL | http://www.haleon.com |
| Investor Relations URL | N/A |
| HQ State/Province | Surrey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Mid Cap Core |
| Next Earnings Release | Feb. 24, 2027 (est.) |
| Last Earnings Release | Jul. 30, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 14, 2026 |
Profile
| Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom. |
| URL | http://www.haleon.com |
| Investor Relations URL | N/A |
| HQ State/Province | Surrey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Mid Cap Core |
| Next Earnings Release | Feb. 24, 2027 (est.) |
| Last Earnings Release | Jul. 30, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 14, 2026 |